These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23592827)

  • 1. Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe.
    Branda JA; Strle F; Strle K; Sikand N; Ferraro MJ; Steere AC
    Clin Infect Dis; 2013 Aug; 57(3):333-40. PubMed ID: 23592827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa.
    Wormser GP; Tang AT; Schimmoeller NR; Bittker S; Cooper D; Visintainer P; Aguero-Rosenfeld ME; Ogrinc K; Strle F; Stanek G
    Med Microbiol Immunol; 2014 Feb; 203(1):65-71. PubMed ID: 24218117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
    Branda JA; Linskey K; Kim YA; Steere AC; Ferraro MJ
    Clin Infect Dis; 2011 Sep; 53(6):541-7. PubMed ID: 21865190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.
    Branda JA; Strle K; Nigrovic LE; Lantos PM; Lepore TJ; Damle NS; Ferraro MJ; Steere AC
    Clin Infect Dis; 2017 Apr; 64(8):1074-1080. PubMed ID: 28329259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of the ZEUS Borrelia VlsE1/pepC10 assay in European LB patients: a case-control study.
    Baarsma ME; Vrijlandt A; Ursinus J; Zaaijer HL; Jurriaans S; van Dam AP; Hovius JW
    Eur J Clin Microbiol Infect Dis; 2022 Mar; 41(3):387-393. PubMed ID: 34806121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples.
    Pegalajar-Jurado A; Schriefer ME; Welch RJ; Couturier MR; MacKenzie T; Clark RJ; Ashton LV; Delorey MJ; Molins CR
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29743307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of serologic tests for lyme disease.
    Steere AC; McHugh G; Damle N; Sikand VK
    Clin Infect Dis; 2008 Jul; 47(2):188-95. PubMed ID: 18532885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
    Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
    Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C6 Peptide-Based Multiplex Phosphorescence Analysis (PHOSPHAN) for Serologic Confirmation of Lyme Borreliosis.
    Pomelova VG; Korenberg EI; Kuznetsova TI; Bychenkova TA; Bekman NI; Osin NS
    PLoS One; 2015; 10(7):e0130048. PubMed ID: 26147441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative cost-effectiveness of two-tiered testing strategies for serodiagnosis of lyme disease with noncutaneous manifestations.
    Wormser GP; Levin A; Soman S; Adenikinju O; Longo MV; Branda JA
    J Clin Microbiol; 2013 Dec; 51(12):4045-9. PubMed ID: 24068010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic parameters of modified two-tier testing in European patients with early Lyme disease.
    Baarsma ME; Schellekens J; Meijer BC; Brandenburg AH; Souilljee T; Hofhuis A; Hovius JW; van Dam AP
    Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2143-2152. PubMed ID: 32632699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C6 peptide ELISA test in the serodiagnosis of Lyme borreliosis in Sweden.
    Tjernberg I; Krüger G; Eliasson I
    Eur J Clin Microbiol Infect Dis; 2007 Jan; 26(1):37-42. PubMed ID: 17180348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Rapid Quidel Sofia 2 Lyme Immunoassay as a First-Tier Test in a Two-Tier Testing Algorithm for Lyme Disease: Comparison to the Zeus ELISA Borrelia VlsE1/pepC10 IgG/IgM Assay Followed by Immunoblot.
    Lewandrowski EL; Branda JA; Lewandrowski K; Turbett S
    Am J Clin Pathol; 2023 Jul; 160(1):58-61. PubMed ID: 36881650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological diagnostics of Lyme borreliosis: comparison of assays in twelve clinical laboratories in Northern Europe.
    Lager M; Dessau RB; Wilhelmsson P; Nyman D; Jensen GF; Matussek A; Lindgren PE; Henningsson AJ; ; Baqir H; Serrander L; Johansson M; Tjernberg I; Skarstein I; Ulvestad E; Grude N; Pedersen AB; Bredberg A; Veflingstad R; Wass L; Aleke J; Nordberg M; Nyberg C; Perander L; Bojesson C; Sjöberg E; Lorentzen ÅR; Eikeland R; Noraas S; Henriksson GA; Petrányi G
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1933-1945. PubMed ID: 31399914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Performance of the Novel BioPlex Lyme Serological Assays in European Patients with Lyme Disease.
    Baarsma ME; Ursinus J; Zaaijer HL; Kuiper H; Hovius JW
    J Clin Microbiol; 2021 Jun; 59(7):e0320520. PubMed ID: 33883179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of bioMérieux's Dissociated Vidas Lyme IgM II and IgG II as a First-Tier Diagnostic Assay for Lyme Disease.
    Molins CR; Delorey MJ; Replogle A; Sexton C; Schriefer ME
    J Clin Microbiol; 2017 Jun; 55(6):1698-1706. PubMed ID: 28330884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia.
    Davis IRC; McNeil SA; Allen W; MacKinnon-Cameron D; Lindsay LR; Bernat K; Dibernardo A; LeBlanc JJ; Hatchette TF
    J Clin Microbiol; 2020 Jun; 58(7):. PubMed ID: 32321781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C6 peptide enzyme immunoassay in Lyme borreliosis serology.
    Rouhiainen M; Pietikäinen A; Kortela E; Kanerva MJ; Oksi J; Hytönen J
    J Microbiol Methods; 2021 Jan; 180():106122. PubMed ID: 33326821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.
    Wormser GP; Schriefer M; Aguero-Rosenfeld ME; Levin A; Steere AC; Nadelman RB; Nowakowski J; Marques A; Johnson BJ; Dumler JS
    Diagn Microbiol Infect Dis; 2013 Jan; 75(1):9-15. PubMed ID: 23062467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
    Zajkowska JM; Kondrusik M; Pancewicz SA; Grygorczuk S; Jamiołkowski J; Stalewska J
    Pol Merkur Lekarski; 2007 Aug; 23(134):95-9. PubMed ID: 18044336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.